Altogen Biosystems Launches Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services

13-Mar-2008

Altogen Biosystems announced launch of new contract research services. Located in Las Vegas, NV, Altogen Custom Services focus on providing specialized biotechnology and pharmaceutical services, including RNA interference (RNAi) services, generation of stably-expressing cell lines, assay development, screening and transfection services.

Generation of stably-expressing cancer cell lines and primary cells can be very expensive and time-consuming. Utilizing this method, investigators are able to develop cells that permanently express specific genes through their incorporation in the cellular genome. Altogen Custom Services offers generation of stable cell lines by transforming the cell line of choice to stably express vector or gene of interest. Optional cloning and shRNA expression services are available.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances